JP2020527574A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527574A5
JP2020527574A5 JP2020502343A JP2020502343A JP2020527574A5 JP 2020527574 A5 JP2020527574 A5 JP 2020527574A5 JP 2020502343 A JP2020502343 A JP 2020502343A JP 2020502343 A JP2020502343 A JP 2020502343A JP 2020527574 A5 JP2020527574 A5 JP 2020527574A5
Authority
JP
Japan
Prior art keywords
joint
pharmaceutical composition
items
knee
cooling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020502343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527574A (ja
JP7282736B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/043094 external-priority patent/WO2019018769A1/en
Publication of JP2020527574A publication Critical patent/JP2020527574A/ja
Publication of JP2020527574A5 publication Critical patent/JP2020527574A5/ja
Priority to JP2023081213A priority Critical patent/JP7738031B2/ja
Application granted granted Critical
Publication of JP7282736B2 publication Critical patent/JP7282736B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020502343A 2017-07-20 2018-07-20 カプサイシンを使用した疼痛の治療のための方法及び組成物 Active JP7282736B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023081213A JP7738031B2 (ja) 2017-07-20 2023-05-17 カプサイシンを使用した疼痛の治療のための方法及び組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762535003P 2017-07-20 2017-07-20
US62/535,003 2017-07-20
PCT/US2018/043094 WO2019018769A1 (en) 2017-07-20 2018-07-20 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023081213A Division JP7738031B2 (ja) 2017-07-20 2023-05-17 カプサイシンを使用した疼痛の治療のための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2020527574A JP2020527574A (ja) 2020-09-10
JP2020527574A5 true JP2020527574A5 (cg-RX-API-DMAC7.html) 2021-08-26
JP7282736B2 JP7282736B2 (ja) 2023-05-29

Family

ID=65016186

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020502343A Active JP7282736B2 (ja) 2017-07-20 2018-07-20 カプサイシンを使用した疼痛の治療のための方法及び組成物
JP2023081213A Active JP7738031B2 (ja) 2017-07-20 2023-05-17 カプサイシンを使用した疼痛の治療のための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023081213A Active JP7738031B2 (ja) 2017-07-20 2023-05-17 カプサイシンを使用した疼痛の治療のための方法及び組成物

Country Status (11)

Country Link
US (4) US20200206166A1 (cg-RX-API-DMAC7.html)
EP (1) EP3654961B1 (cg-RX-API-DMAC7.html)
JP (2) JP7282736B2 (cg-RX-API-DMAC7.html)
CN (1) CN111201015A (cg-RX-API-DMAC7.html)
AU (1) AU2018302342B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020000989A2 (cg-RX-API-DMAC7.html)
CA (1) CA3069540A1 (cg-RX-API-DMAC7.html)
ES (1) ES3018268T3 (cg-RX-API-DMAC7.html)
IL (1) IL272036B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020000488A (cg-RX-API-DMAC7.html)
WO (1) WO2019018769A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019018769A1 (en) 2017-07-20 2019-01-24 Centrexion Therapeutics Corporation METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE
EP3840739B1 (en) * 2018-08-24 2025-11-12 Centrexion Therapeutics Corporation Capsaicin sequential dosing method for treatment of knee joint pain
CN114028540B (zh) * 2021-11-26 2023-10-17 海南鑫开源医药科技有限公司 一种具有镇痛作用的组合物、微针贴片及其制备方法以及应用
CN115006379B (zh) * 2021-12-28 2023-12-15 南京清普生物科技有限公司 一种trpv1激动剂原位膜剂组合物,及其制备方法和用途
US12233115B2 (en) * 2022-09-30 2025-02-25 Extend Biosciences, Inc. Long-acting parathyroid hormone

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599342A (en) 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US5099030A (en) 1987-03-09 1992-03-24 The Procter & Gamble Company Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
US5021450A (en) 1989-05-30 1991-06-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
US5985860A (en) 1992-06-03 1999-11-16 Toppo; Frank System for transdermal delivery of pain relieving substances
US5318960A (en) 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
DE59408028D1 (de) 1993-09-30 1999-05-06 Medichemie Ag Capsaicin enthaltendes Arzneimittel zur Behandlung chronischer Rhinopathie
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
WO1998020867A1 (en) 1996-11-15 1998-05-22 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
US6060060A (en) 1997-01-31 2000-05-09 Bmb Patent Holding Corporation Analgesic compositions from sweet peppers and methods of use thereof
EP1201241B8 (en) 1997-03-13 2010-10-27 James N. Campbell Compositions containing capsaicin or capsaicin analogues and an anesthetic
JP2002514221A (ja) 1997-05-27 2002-05-14 アルゴス ファーマシューティカル コーポレーション カプサイシノイド及びその強化薬を含有する鎮痛薬組成物
CA2442049C (en) 2001-03-22 2010-06-01 Michael J. Iadarola Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist
US20040146590A1 (en) 2001-03-22 2004-07-29 Iadarola Michael J Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
US20030104085A1 (en) 2001-12-05 2003-06-05 Yeomans David C. Methods and compositions for treating back pain
WO2004009064A1 (de) 2002-07-19 2004-01-29 Mestex Ag Verwendung von neurotoxischen substanzen für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels
NZ540769A (en) 2002-12-18 2009-03-31 Algorx Pharmaceuticals Inc Administration of capsaicinoids for the treatment of pain
WO2004056305A2 (en) 2002-12-18 2004-07-08 Algorx Administration of capsaicinoids
US7943166B2 (en) 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
EP2311437A1 (en) 2003-12-19 2011-04-20 Novo Nordisk Health Care AG Stabilised compositions of factor VII polypeptides
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN101119713A (zh) * 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
WO2006066419A1 (de) 2004-12-22 2006-06-29 Mestex Ag Mischung eines vanilloidrezeptoragonisten mit einer nervenregenerationshemmenden substanz, ihre verwendung für die herstellung eines schmerzmittels und verfahren zur applikation dieses mittels
EP1838301B1 (de) 2004-12-28 2015-01-28 Mestex AG Verwendung von resiniferatoxin (rtx) für die herstellung eines mittels zur behandlung von schmerzen
ES2384244T3 (es) 2004-12-28 2012-07-02 Mestex Ag Utilización de un agonista del receptor vaniloide juntamente con un glicosaminoglicano o un proteoglicano para la fabricación de un fármaco para el tratamiento de los dolores articulares y procedimiento para la aplicación de este fármaco
WO2006105481A1 (en) * 2005-03-30 2006-10-05 Neurogesx, Inc. Low-concentration capsaicin patch and methods for treating neuropathic pain
US20080160487A1 (en) 2006-12-29 2008-07-03 Fairfield Language Technologies Modularized computer-aided language learning method and system
US8158682B2 (en) 2008-09-12 2012-04-17 Vallinex, Inc. Instillation administration of capsaicinoids for the treatment of pain
CN101507818B (zh) 2008-12-15 2010-11-10 中国人民武装警察部队医学院 辣椒碱β-环糊精包合物及包合物的脂质体及凝胶
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20130303495A1 (en) 2009-12-31 2013-11-14 Sov Therapeutics Emulsion formulations
ES2821490T3 (es) * 2010-03-30 2021-04-26 The Childrens Res Institute Aparato y método de algometría humana
KR101769010B1 (ko) * 2011-09-09 2017-08-17 비쭈리 헬스 사이언스 엘엘씨 Trpv1 선택적 작용제를 포함하는 통증 완화 조성물, 및 이의 제조방법 및 용도
US9566187B2 (en) 2012-03-13 2017-02-14 Breg, Inc. Cold therapy systems and methods
WO2013158814A1 (en) 2012-04-18 2013-10-24 Mallinckrodt Llc Immediate release, abuse deterrent pharmaceutical compositions
EP2838536B1 (en) 2012-04-18 2017-08-09 Mallinckrodt LLC Immediate release pharmaceutical compositions with abuse deterrent properties
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US20150190509A1 (en) 2012-08-03 2015-07-09 Mestex Ag Resiniferatoxin solution
US20140142073A1 (en) * 2012-11-12 2014-05-22 Api Genesis, Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
GB201317756D0 (en) 2013-10-08 2013-11-20 Critical Pharmaceuticals Ltd New process
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
GB201319792D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US20150133561A1 (en) * 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
ES2838756T3 (es) 2014-01-24 2021-07-02 Sentiss Pharma Private Ltd Composición farmacéutica que comprende brinzolamida
MX2016013486A (es) 2014-04-14 2017-05-10 Flex Pharma Inc Activadores de canales ionicos y metodos de uso.
KR102073258B1 (ko) 2014-04-15 2020-02-04 비쭈리 헬스 사이언스 엘엘씨 통증 완화용 국소 조성물, 제조방법 및 용도
CN105030760B (zh) 2014-04-24 2018-10-02 长弘生物科技股份有限公司 稳定医药组合物
US10736842B2 (en) 2014-06-25 2020-08-11 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
EA033046B1 (ru) 2014-06-25 2019-08-30 НУКАНА ПиЭлСи Состав, содержащий пролекарство гемцитабина
EP3182968A4 (en) 2014-08-19 2018-05-09 Muzari, Mandishora Israel Capsaicinoids and uses thereof as medicaments
US20180311189A1 (en) 2014-11-13 2018-11-01 Centrexion Therapeutics Corporation Capsaicinoids for Use in Treating ACRAL Lick Granuloma
US9359316B1 (en) 2014-11-25 2016-06-07 Concentric Analgesics, Inc. Prodrugs of phenolic TRPV1 agonists
US20180021286A1 (en) 2015-02-02 2018-01-25 Enspire Group LLC Stabilized dialkyl fumarate compositions
CA2987517A1 (en) 2015-05-29 2016-12-08 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
EP3302442B1 (en) 2015-06-03 2024-10-16 Triastek, Inc. Dosage forms and use thereof
US20200261409A1 (en) 2015-11-20 2020-08-20 Sorrento Therapeutics, Inc. Methods for pain treatment using resiniferatoxin
US20190022036A1 (en) 2016-01-22 2019-01-24 Centrexion Therapeutics Corporation Capsaicin sequential dosing method for treatment of morton's neuroma pain
US10851123B2 (en) 2016-02-23 2020-12-01 Concentric Analgesics, Inc. Prodrugs of phenolic TRPV1 agonists
CA3025268A1 (en) 2016-05-25 2017-11-30 Concentric Analgesics, Inc. Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
US11000490B2 (en) 2016-11-02 2021-05-11 Centrexion Therapeutics Corporation Stable aqueous capsaicin injectable formulations and medical uses thereof
WO2018217937A1 (en) 2017-05-24 2018-11-29 Concentric Analgesics, Inc. Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
WO2019018769A1 (en) * 2017-07-20 2019-01-24 Centrexion Therapeutics Corporation METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE

Similar Documents

Publication Publication Date Title
JP6050902B2 (ja) 即効型インスリン組成物
CN119424615A (zh) Gip/glp1激动剂组合物
MX2007006253A (es) Formulacion de gel de capsaicinoide y usos para esta.
JP2019537589A5 (cg-RX-API-DMAC7.html)
EP2739266B1 (en) Stable anti-inflammatory solutions for injection
KR20190101368A (ko) 안정한 수성의 캡사이신 주사 가능한 제형 및 이의 의학적 용도
JP2023116457A (ja) カプサイシンを使用した疼痛の治療のための方法及び組成物
JP6196704B2 (ja) 神経因性疾病の治療のための医薬
RU2487707C2 (ru) Применение парацетамола и ибупрофена в лечении
CA2720987A1 (en) Dosages and methods for the treatment of cancer
TW201105341A (en) Pharmacetical composition for inhibitng pain
CN108354898B (zh) 一种治疗类风湿性关节炎的透皮给药制剂及其制备方法
JP2014522414A5 (cg-RX-API-DMAC7.html)
JP2021534207A5 (cg-RX-API-DMAC7.html)
US20130137769A1 (en) Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts
US20060216338A1 (en) Composition and method of treatment for heel pain
CN1233316C (zh) 阿魏提取物的制药用途
JP2022185071A (ja) 関節疾患処置用組成物およびこれを含むキット
JP6580306B2 (ja) 外用医薬組成物
WO2022178018A1 (en) Liquid unit dosage forms for treatment of pain
US11813237B2 (en) Creatine, its derivatives, compositions and methods of use thereof
CN101677943B (zh) 使用苯甲醇的多剂量浓缩艾司洛尔
CN106413699B (zh) 外用药物组合物
KR102926625B1 (ko) 지방분해용 주사제 조성물
CN112472667B (zh) 一种维他昔布长效注射液及其制备方法和应用